228 related articles for article (PubMed ID: 18221985)
1. Intravenous gammaglobulin and thalidomide may be an effective therapeutic combination in refractory scleromyxedema: case report and discussion of the literature.
Efthimiou P; Blanco M
Semin Arthritis Rheum; 2008 Dec; 38(3):188-94. PubMed ID: 18221985
[TBL] [Abstract][Full Text] [Related]
2. Managing scleromyxedema with intravenous immunoglobulin: acute worsening of scleromyxedema with biclonal gammopathy.
Manousaridis I; Loeser C; Goerdt S; Hassel JC
Acta Dermatovenerol Alp Pannonica Adriat; 2010 Dec; 19(4):15-9. PubMed ID: 21390475
[TBL] [Abstract][Full Text] [Related]
3. Scleromyxedema without paraproteinemia.
Abarzúa AA; Giesen LF; Sandoval MO; González SB
Int J Dermatol; 2014 Aug; 53(8):971-4. PubMed ID: 24527753
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of intravenous immunoglobulin in the treatment of scleromyxoedema].
Sillard L; Passeron T; Cardot-Leccia N; Perrin C; Lacour JP; Ortonne JP
Ann Dermatol Venereol; 2010 Jan; 137(1):48-52. PubMed ID: 20110069
[TBL] [Abstract][Full Text] [Related]
5. Scleromyxedema: a multicenter study of characteristics, comorbidities, course, and therapy in 30 patients.
Rongioletti F; Merlo G; Cinotti E; Fausti V; Cozzani E; Cribier B; Metze D; Calonje E; Kanitakis J; Kempf W; Stefanato CM; Marinho E; Parodi A
J Am Acad Dermatol; 2013 Jul; 69(1):66-72. PubMed ID: 23453242
[TBL] [Abstract][Full Text] [Related]
6. [Response to thalidomide in scleromyxedema].
Pascualini MF; Caballero Escuti G; Valente E; Kurpis M; Ruiz Lascano A
Medicina (B Aires); 2013; 73(3):252-4. PubMed ID: 23732202
[TBL] [Abstract][Full Text] [Related]
7. Scleromyxedema.
Hummers LK
Curr Opin Rheumatol; 2014 Nov; 26(6):658-62. PubMed ID: 25215418
[TBL] [Abstract][Full Text] [Related]
8. Vincristine, idarubicin, dexamethasone and thalidomide in scleromyxoedema.
Laimer M; Namberger K; Massone C; Koller J; Emberger M; Pleyer L; Hintner H; Greil R
Acta Derm Venereol; 2009 Nov; 89(6):631-5. PubMed ID: 19997697
[TBL] [Abstract][Full Text] [Related]
9. Scleromyxedema: successful treatment with thalidomide in two patients.
Amini-Adle M; Thieulent N; Dalle S; Balme B; Thomas L
Dermatology; 2007; 214(1):58-60. PubMed ID: 17191049
[TBL] [Abstract][Full Text] [Related]
10. Scleromyxedema--thalidomide therapy.
Martins A; Paiva Lopes MJ; Tavares Belo R; Rodrigues JC
J Eur Acad Dermatol Venereol; 2008 May; 22(5):622-4. PubMed ID: 18312333
[No Abstract] [Full Text] [Related]
11. Scleromyxedema: a case series highlighting long-term outcomes of treatment with intravenous immunoglobulin (IVIG).
Blum M; Wigley FM; Hummers LK
Medicine (Baltimore); 2008 Jan; 87(1):10-20. PubMed ID: 18204366
[TBL] [Abstract][Full Text] [Related]
12. An unusual presentation of scleromyxedema as inflammatory myopathy.
Vysakha KV; Poyuran R; Nair SS; Nair M
Acta Myol; 2019 Mar; 38(1):13-16. PubMed ID: 31309176
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin therapy for scleromyxedema: a case report and review of literature.
Sroa N; Campbell S; Bechtel M
J Drugs Dermatol; 2010 Mar; 9(3):263-5. PubMed ID: 20232589
[TBL] [Abstract][Full Text] [Related]
14. Case report: Scleromyxedema associated with a monoclonal gammapathy: Successful treatment with intravenous immunoglobulins.
Wang SS; Chen QY; Xiang LH
Front Immunol; 2022; 13():1099918. PubMed ID: 36713453
[TBL] [Abstract][Full Text] [Related]
15. Combination of intravenous immunoglobulins and lenalidomide in the treatment of scleromyxedema.
Brunet-Possenti F; Hermine O; Marinho E; Crickx B; Descamps V
J Am Acad Dermatol; 2013 Aug; 69(2):319-20. PubMed ID: 23866873
[No Abstract] [Full Text] [Related]
16. Treatment of scleromyxedema and the dermatoneuro syndrome with intravenous immunoglobulin.
Rey JB; Luria RB
J Am Acad Dermatol; 2009 Jun; 60(6):1037-41. PubMed ID: 19249127
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of intravenous immunoglobulin in Arndt-Gottron scleromyxedema].
Lopez L; Wierzbicka-Hainaut E; Villers A; Guillet G
Ann Dermatol Venereol; 2009 Apr; 136(4):330-6. PubMed ID: 19361699
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Efficacy of Treatment with Intravenous Immunoglobulin in Scleromyxedema.
Baglama Š; Trčko K
Acta Dermatovenerol Croat; 2020 Jul; 28(1):24-28. PubMed ID: 32650847
[TBL] [Abstract][Full Text] [Related]
19. Scleromyxoedema with associated peripheral neuropathy: successful treatment with thalidomide.
Peter LM; Ammoury A; Chiavassa-Gandois H; Lamant L; Paul CF
Clin Exp Dermatol; 2008 Aug; 33(5):606-10. PubMed ID: 18477005
[TBL] [Abstract][Full Text] [Related]
20. Scleromyxoedema: the importance of physical examination.
Pipa S; Sá J; Mondragão A; Marinho A
BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30317211
[No Abstract] [Full Text] [Related]
[Next] [New Search]